Genetic polymorphisms significantly contribute to pyroptosis heterogeneity in COPD, with genome-wide association studies identifying specific variants in NLRP3, CARD8, and IL-1β genes that associate with disease susceptibility and progression trajectories (89). This evidence concerns the gene IL1B and chronic obstructive pulmonary disease.